We are independent & ad-supported. We may earn a commission for purchases made through our links.

Advertiser Disclosure

Our website is an independent, advertising-supported platform. We provide our content free of charge to our readers, and to keep it that way, we rely on revenue generated through advertisements and affiliate partnerships. This means that when you click on certain links on our site and make a purchase, we may earn a commission. Learn more.

How We Make Money

We sustain our operations through affiliate commissions and advertising. If you click on an affiliate link and make a purchase, we may receive a commission from the merchant at no additional cost to you. We also display advertisements on our website, which help generate revenue to support our work and keep our content free for readers. Our editorial team operates independently from our advertising and affiliate partnerships to ensure that our content remains unbiased and focused on providing you with the best information and recommendations based on thorough research and honest evaluations. To remain transparent, we’ve provided a list of our current affiliate partners here.

What are Oligodendrocytes?

By S. Gadd
Updated Mar 03, 2024
Our promise to you
The Health Board is dedicated to creating trustworthy, high-quality content that always prioritizes transparency, integrity, and inclusivity above all else. Our ensure that our content creation and review process includes rigorous fact-checking, evidence-based, and continual updates to ensure accuracy and reliability.

Our Promise to you

Founded in 2002, our company has been a trusted resource for readers seeking informative and engaging content. Our dedication to quality remains unwavering—and will never change. We follow a strict editorial policy, ensuring that our content is authored by highly qualified professionals and edited by subject matter experts. This guarantees that everything we publish is objective, accurate, and trustworthy.

Over the years, we've refined our approach to cover a wide range of topics, providing readers with reliable and practical advice to enhance their knowledge and skills. That's why millions of readers turn to us each year. Join us in celebrating the joy of learning, guided by standards you can trust.

Editorial Standards

At The Health Board, we are committed to creating content that you can trust. Our editorial process is designed to ensure that every piece of content we publish is accurate, reliable, and informative.

Our team of experienced writers and editors follows a strict set of guidelines to ensure the highest quality content. We conduct thorough research, fact-check all information, and rely on credible sources to back up our claims. Our content is reviewed by subject matter experts to ensure accuracy and clarity.

We believe in transparency and maintain editorial independence from our advertisers. Our team does not receive direct compensation from advertisers, allowing us to create unbiased content that prioritizes your interests.

Oligodendrocytes, also known as oligodendroglia, are a type of brain cell in the central nervous system that belongs to the glial cell family. The main purpose of glial cells is maintenance and support of nervous system cells. Oligodendrocytes support neurons by producing a substance called myelin, which is composed of approximately 80 percent lipid and 20 percent protein. Essentially, oligodendrocytes wrap the fatty myelin around the nerve-transmitting extensions of nerve cells, which are called axons. These myelin sheaths are approximately .039 inches (about 1 mm) thick, and this sheath acts as insulation for axons – this results in the fast conduction of nerve impulses along axons.

Schwann cells are another type of glial cell that similarly functions to supply myelination to axons. There are, however, several crucial differences between Schwann cells and oligodendrocytes. First, Schwann cells myelinate neurons in the peripheral nervous system, whereas oligodendrocytes myelinate neurons in the central nervous system. Second, a single oligodendrocyte has the capacity to myelinate up to approximately 50 axons, whereas Schwann cells can myelinate only one axon.

Oligodendrocytes arise from oligodendrocyte precursor cells (OPC). In general, a precursor cell is a type of partially differentiated cell that retains the ability to differentiate into several functionally related cell types, but has lost the ability to differentiate into multiple cell types. Small populations of OPCs remain in adults, and OPCs are thought to compose approximately 5 to 10 percent of the adult glial cell population. In response to certain mechanical injuries or viral infections, it is believed that these OPCs are stimulated to grow and replace damaged oligodendrocytes in healthy individuals, resulting in remyelination of neurons.

The myelin sheaths can be compared to the insulation on electrical wires, preventing leakage of ions and maintaining the electrical potential of axons. Therefore, a myelinated axon is much more efficient at transducing signal than an unmyelinated axon. There are several pathological conditions associated with the demyelination of axons, the most common of which is multiple sclerosis (MS).

MS is an autoimmune disease in which the immune system attacks and damages the myelin sheath, resulting in faulty transduction of nerve signals along axons. Leukodystrophies arise from insufficient myelin production during growth, resulting in a variety of symptoms that include the slowing of mental and physical development, progressive loss of movement, and progressive deterioration of senses, such as vision and hearing. Other conditions associated with damage to oligodendrocytes include cerebral palsy, the disabilities resulting from a stroke, and paralysis caused by spinal cord injury.

The Health Board is dedicated to providing accurate and trustworthy information. We carefully select reputable sources and employ a rigorous fact-checking process to maintain the highest standards. To learn more about our commitment to accuracy, read our editorial process.

Discussion Comments

By Mammmood — On Oct 01, 2011

@SkyWhisperer - I believe that we will get there too. However, I think we should tread carefully with claims of miracle cures for the time being.

I knew someone who had muscular sclerosis and while he was getting treatment that kept him from getting worse, he was not cured from what I could tell.

I did some research online and read that some scientists had claimed to have done things with stem cells to cure – or at least combat – the progression of muscular sclerosis.

Indeed, finding a cure muscular sclerosis was held up as one of the rationales for accelerated investment into stem cell research. I couldn’t find any solid evidence to back up the claims as of yet; so far, I’ve read only anecdotal accounts. But again, like you, I do believe we will find a cure some day.

By SkyWhisperer — On Sep 30, 2011

So that’s what causes muscular sclerosis, a breakdown in the oligodendrocytes myelin function. Given how important this “insulation” is to ensuring the body can properly transmit nerve impulses, I would hope that medical science would be looking for ways to remedy the condition.

I can see that it would be a tall order to prescribe some treatment that would effectively reinsulate your nerves, so to speak, given that the nerve transmitting axons are so abundant in the body.

I think you would have to find some way to stimulate myelin growth in the body, or perhaps inject stem cells or something like that which have the capability of regrowing the myelin on its own.

I don’t doubt that with the advances in medical science, we will soon find such a breakthrough.

The Health Board, in your inbox

Our latest articles, guides, and more, delivered daily.

The Health Board, in your inbox

Our latest articles, guides, and more, delivered daily.